At 14.2x earnings and 11.9x forward earnings, the stock is priced like a no-growth, late-cycle commodity operator despite maintaining positive profitability metrics. A 2.3 Altman Z-Score places it in the grey zone—neither distressed nor bulletproof—while a Piotroski F-Score of 6 signals operational stability but not elite balance sheet strength. The market is assigning a modest 2.7x sales and 1.5x book multiple to a company generating 9.20% ROIC and 8.50% operating margins, suggesting muted expectations rather than exuberance. This is not a deep value bankruptcy bet, but it is also not being priced as a high-growth compounder; it sits in an awkward middle ground where execution must improve to justify multiple expansion.